血清碱性磷酸酶降低可能提示骨质疏松门诊患者中的低磷酸酯酶症
这项回顾性研究分析了8年间(2012-2020年)就诊于三级医院骨质疏松门诊的1839例患者,发现9%至少一次碱性磷酸酶(ALP)降低,0.4%持续降低,5例诊断为低磷酸酯酶症(HPP),在至少一次低ALP患者中HPP患病率为3%。全院患者中低ALP占0.6%,22例非典型股骨骨折中2例低ALP。持续低ALP易于识别,提示HPP可能,该病可能被误诊为骨质疏松并错误地接受抗骨吸收治疗。
要点
- 骨质疏松门诊患者中9%至少一次ALP降低,0.4%持续降低,HPP患病率0.3%。
- 在至少一次低ALP的患者中,HPP患病率为3%。
- 低ALP是HPP的筛查工具,HPP可能被抗骨吸收治疗加重。
核心结论
- 骨质疏松门诊就诊者中持续低ALP易于识别,提示低磷酸酯酶症可能,该病可能被误诊为骨质疏松并错误地接受抗骨吸收治疗。
研究设计与样本
- 回顾性研究,纳入8年间(2012-2020年)就诊于三级医院骨质疏松门诊的1839例患者,并根据ALP降低情况分类;同时评估全院记录和非典型股骨骨折患者组的ALP水平。
主要发现
- 1839例骨质疏松门诊患者中,168例(9%)至少一次ALP降低,50例(2.7%)低ALP持续≥2个月,7例(0.4%)持续低ALP。
- 5例诊断为HPP,其中4例为持续低ALP;骨质疏松门诊中HPP患病率为0.3%,在至少一次低ALP患者中为3%。
- 全院患者中低ALP发生率为0.6%,22例非典型股骨骨折患者中2例低ALP。
关键数值与推荐
- 低ALP定义为< 30 IU/L。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Low serum alkaline phosphatase (ALP) was found in 9% of patients attending an osteoporosis clinic, 0.6% of hospital patients, and 2/22 with an atypical femoral fracture. Hypophosphatasia was diagnosed in 3% of osteoporosis clinic patients with low ALP. Low ALP is a screening tool for hypophosphatasia, a condition potentially aggravated by antiresorptive therapy. INTRODUCTION: Hypophosphatasia (HPP) is an inherited disorder associated with impaired primary mineralisation of osteoid (osteomalacia). HPP may be misdiagnosed as osteoporosis, a reduction in the volume of normally mineralized bone. Both illnesses may result in fragility fractures, although stress and atypical fractures are more common in HPP. Antiresorptive therapy, first-line treatment for osteoporosis, is relatively contraindicated in HPP. Misdiagnosis and mistreatment can be avoided by recognising a low serum alkaline phosphatase (ALP). Our aim was to determine the prevalence of a low ALP (< 30 IU/L) in patients attending an osteoporosis clinic, in a hospital-wide setting, and in a group of patients with atypical femoral fractures (AFF). METHODS: This was a retrospective study of patients attending an osteoporosis clinic at a tertiary hospital during 8 years (2012-2020). Patients were categorised into those with a transiently low ALP, those with low ALP on ≥ 2 occasions but not the majority of measurements, and those with a persistently low ALP. ALP levels were also assessed in hospital-wide records and a group of patients with AFF. RESULTS: Of 1839 patients attending an osteoporosis clinic, 168 (9%) had ≥ 1 low ALP, 50 (2.7%) had low ALP for ≥ 2 months, and seven (0.4%) had persistently low ALP levels. HPP was diagnosed in five patients, four of whom had persistently low ALP levels. The prevalence of HPP was 0.3% in the osteoporosis clinic and 3% in patients with ≥ 1 low ALP. Low ALP occurred in 0.6% of all hospital patients and 2/22 with AFF. CONCLUSION: Persistently low ALP in osteoporosis clinic attendees is easy to identify and signals the possibility of hypophosphatasia, a condition that may be mistaken for osteoporosis and incorrectly treated with antiresorptive therapy.
引用
- Ng E, Ashkar C, Seeman E, et al. A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients. Osteoporos Int. 2022. PMID: 36434431. doi:10.1007/s00198-022-06597-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。